Oxipurinol
Alternative Names: Alloxanthine; Oxyprim; OxypurinolLatest Information Update: 01 Jun 2020
At a glance
- Originator GlaxoSmithKline
- Developer Cardiome Pharma
- Class Anti-ischaemics; Antigouts; Antivirals; Pyrazoles; Pyrimidines; Small molecules; Urologics
- Mechanism of Action Xanthine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gout; Heart failure; Stomatitis
Most Recent Events
- 27 May 2020 Correvio Pharma has been acquired by ADVANZ PHARMA
- 15 May 2018 Cardiome Pharma is now called Correvio Pharma
- 28 Feb 2006 Oxypurinol is available for partnering worldwide for the treatment of conjestive heart failure and gout (www.cardiome.com)